Direct agonist/antagonist functions of dehydroepiandrosterone

Endocrinology

Volumn 146, Issue 11, 2005, Pages 4568-4576

  Chen, Fang ^a   Knecht, Kristin ^a   Birzin, Elizabeth ^a   Fisher, John ^a   Wilkinson, Hilary ^a   Mojena, Marina ^b   Moreno, Consuelo Tudela ^b   Schmidt, Azriel ^a   Harada, Shun Ichi ^a   Freedman, Leonard P ^a   Reszka, Alfred A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Medical affairs Merck sharp and Dohme ltd   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HORMONE RECEPTOR; PRASTERONE; PROSTATE SPECIFIC ANTIGEN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL GROWTH; CELL LINE; CONTROLLED STUDY; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE;

ANIMALS; CELL DIVISION; CELL LINE; DEHYDROEPIANDROSTERONE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC;

EID: 26844434734     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0368     Document Type: Article

References (38)

1. Auchus RJ, Rainey WE 2004 Adrenarche - physiology, biochemistry and human disease. Clin Endocrinol (Oxf) 60:288-296
2. Labrie F, Luu-The V, Labrie C, Simard J 2001 DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol 22:185-212
3. Stewart P 2002 The adrenal cortex. Philadelphia: Saunders
4. Arnold JT, Le H, McFann KK, Blackman MR 2005 Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Am J Physiol Endocrinol Metab 288:E573-E584
5. Mohler JL, Gregory CW, Ford 3rd OH, Kim D, Weaver CM, Petrusz P, Wilson EM, French FS 2004 The androgen axis in recurrent prostate cancer. Clin Cancer Res 10:440-448
6. Dharia S, Parker Jr CR 2004 Adrenal androgens and aging. Semin Reprod Med 22:361-368
7. Baker ME 2004 Co-evolution of steroidogenic and steroid-inactivating enzymes and adrenal and sex steroid receptors. Mol Cell Endocrinol 215:55-62
8. Valenti G 2004 Neuroendocrine hypothesis of aging: the role of corticoadrenal steroids. J Endocrinol Invest 27:62-63
9. Libe R, Barbetta L, Dall'Asta C, Salvaggio F, Gala C, Beck-Peccoz P, Ambrosi B 2004 Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. J Endocrinol Invest 27:736-741
10. Arlt W 2004 Dehydroepiandrosterone replacement therapy. Semin Reprod Med 22:379-388
11. Chen CC, Parker Jr CR 2004 Adrenal androgens and the immune system. Semin Reprod Med 22:369-377
12. Legrain S, Girard L 2003 Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects. Drugs Aging 20:949-967
13. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
14. McPhaul MJ, Young M 2001 Complexities of androgen action. J Am Acad Dermatol 45:S87-S94
15. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
16. Holterhus PM, Piefke S, Hiort O 2002 Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs. J Steroid Biochem Mol Biol 82:269-275
17. Chen F, Knecht K, Leu C, Rutledge SJ, Scafonas A, Gambone C, Vogel R, Zhang H, Kasparcova V, Bai C, Harada S, Schmidt A, Reszka A, Freedman L 2004 Partial agonist/antagonist properties of androstenedione and 4-androsten-3β,17β-diol. J Steroid Biochem Mol Biol 91:247-257
18. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870
19. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S 1998 Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol Pharmacol 54:105-112
20. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR 1996 GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 93:4948-4952
21. Steketee K, Timmerman L, Ziel-van der Made AC, Doesburg P, Brinkmann AO, Trapman J 2002 Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer. Int J Cancer 100:309-317
22. Tan J, Sharief Y, Hamil KG, Gregory CW, Zang DY, Sar M, Gumerlock PH, DeVere White RW, Pretlow TG, Harris SE, Wilson EM, Mohler JL, French FS 1997 Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol 11:450-459
23. Koh E, Kanaya J, Namiki M 2001 Adrenal steroids in human prostatic cancer cell lines. Arch Androl 46:117-125
24. Maggiolini M, Recchia AG, Carpino A, Vivacqua A, Fasanella G, Rago V, Pezzi V, Briand PA, Picard D, Ando S 2004 Oestrogen receptor β is required for androgen-stimulated proliferation of LNCaP prostate cancer cells. J Mol Endocrinol 32:777-791
25. Rehman KS, Carr BR 2004 Sex differences in adrenal androgens. Semin Reprod Med 22:349-360
26. Caplan AJ, Jackson S, Smith D 2003 Hsp90 reaches new heights. Conference on the Hsp90 chaperone machine. EMBO Rep 4:126-130
27. Georget V, Terouanne B, Nicolas JC, Sultan C 2002 Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry 41:11824-11831
28. Bruder JM, Sobek L, Oettel M 1997 Dehydroepiandrosterone stimulates the estrogen response element. J Steroid Biochem Mol Biol 62:461-466
29. Lamberts SW, van den Beld AW, van der Lely AJ 1997 The endocrinology of aging. Science 278:419-424
30. Algarte-Genin M, Cussenot O, Costa P 2004 Prevention of prostate cancer by androgens: experimental paradox or clinical reality. Eur Urol 46:285-294; discussion 294-295
31. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE 2004 Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856-1865
32. Williams MR, Dawood T, Ling S, Dai A, Lew R, Myles K, Funder JW, Sudhir K, Komesaroff PA 2004 Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J Clin Endocrinol Metab 89:4708-4715
33. Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR 2003 Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 144:3449-3455
34. Harris HA, Bruner-Tran KL, Zhang X, Osteen KG, Lyttle CR 2005 A selective estrogen receptor-β agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod 20:936-941
35. Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith Jr JC 2003 Evaluation of an estrogen receptor-β agonist in animal models of human disease. Endocrinology 144:4241-4249
36. Rontzsch A, Thoss K, Petrow PK, Henzgen S, Brauer R 2004 Amelioration of murine antigen-induced arthritis by dehydroepiandrosterone (DHEA). Inflamm Res 53:189-198
37. Dulos J, Verbraak E, Bagchus WM, Boots AM, Kaptein A 2004 Severity of murine collagen-induced arthritis correlates with increased CYP7B activity: enhancement of dehydroepiandrosterone metabolism by interleukin-1β. Arthritis Rheum 50:3346-3353
38. Martin C, Ross M, Chapman KE, Andrew R, Bollina P, Seckl JR, Habib FK 2004 CYP7B generates a selective estrogen receptor β agonist in human prostate. J Clin Endocrinol Metab 89:2928-2935